BBH (VanEck Biotech ETF) Stock Analysis - Hedge Fund Holdings
VanEck Biotech ETF (BBH) is a publicly traded the market company. As of May 21, 2026, BBH trades at $144.42 with a market cap of $0 and a P/E ratio of 0.00. BBH moved -1.02% today. Year to date, BBH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns BBH stock?
Hedge funds tracked by Rallies that own BBH include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for VanEck Biotech ETF.
BBH Key Metrics
Key financial metrics for BBH
Metric
Value
Price
$144.42
Market Cap
$0
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$0.00
52-Week Low
$0.00
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding BBH
Citadel Advisors holds 5.78K shares of BBH, changed -73.52% as of Dec 31, 2024.
Two Sigma holds 1.90K shares of BBH, changed -26.92% as of Dec 31, 2024.
BBH Analyst Consensus
BBH analyst coverage data. Average price target: $0.00.
Common questions about BBH
Who owns BBH stock?
Hedge funds tracked by Rallies that own BBH include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for VanEck Biotech ETF.
Does Rallies show 13F holders for BBH?
Yes. Rallies tracks hedge fund and 13F ownership data for BBH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBH. It does not provide personalized investment advice.
